China revises its Good Supply Practice for pharma

Singapore: The newly revised policy on Good Supply Practice for Pharma Products (GSP) was recently adopted at the executive meeting of the Ministry of Heath and officially issued in China. The GSP will go into effect from June 1, 2013.

The revision of GSP is an attempt by China to adjust the policy for supervision of drug distribution. The revised GSP sets higher qualification requirements and higher standards for engaging in drug distribution. As compared to the current GSP, the newly revised GSP has higher requirements for quality management, which will effectively enhance the capability to control drug quality risk in the distribution process.

The revised GSP comprises 187 articles in four chapters, including the General Provisions, Quality Management for Wholesale of Pharmaceutical Products, Quality Management for Retail of Pharmaceutical Products and Supplementary Provisions.